Target Price | $10.70 |
Price | $2.81 |
Potential |
280.78%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Leap Therapeutics, Inc. 2025 .
The average Leap Therapeutics, Inc. target price is $10.70.
This is
280.78%
register free of charge
$16.00
469.40%
register free of charge
$5.50
95.73%
register free of charge
|
|
A rating was issued by 5 analysts: 5 Analysts recommend Leap Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Leap Therapeutics, Inc. stock has an average upside potential 2025 of
280.78%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.98 | -1.93 |
17.43% | 51.51% | |
P/E | negative |
2 Analysts have issued a Leap Therapeutics, Inc. forecast for earnings per share. The average Leap Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Leap Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.